Message Number: FHL4890 | New FHL Archives SearchFrom: Sukie Crandall
Date: Sat, 10 May 2008 13:54:57 -0400
To: fhl <ferrethealth@yahoogroups.com>
Subject: [ferrethealth] abstracts
By using amber glasses and a very low monitor light setting I can=20
tolerate just a few minutes at a time online at this stage of healing=20
so am treating myself and all here to some new abstracts. I will read=20
them later in paper copies because that is more comfy so apologies if=20
any are not appropriate or have been given before.
J Am Vet Med Assoc. 2008 May 1;232(9):1338-43.
Long-term outcome of domestic ferrets treated surgically for=20
hyperadrenocorticism: 130 cases (1995-2004).
Swiderski JK, Seim HB 3rd, MacPhail CM,Campbell TW, Johnston MS,=20
Monnet E.
Department of Clinical Sciences, College of Veterinary Medicine and=20
Biomedical Sciences, Colorado State University, Fort Collins, CO=20
80523, USA.
OBJECTIVE: To determine the long-term survival rate and factors that=20
affect survival time of domestic ferrets treated surgically for=20
hyperadrenocorticism. STUDY DESIGN: Retrospective case series.=20
ANIMALS: 130 ferrets with hyperadrenocorticism that were treated=20
surgically. PROCEDURES: Medical records of ferrets surgically treated=20
for hyperadrenocorticism were reviewed. Data recorded included=20
signalment, duration of clinical signs prior to hospital admission,=20
CBC values, serum biochemical analysis results, anesthetic time,=20
surgical time, concurrent diseases, adrenal gland affected (right,=20
left, or both [bilateral]), histopathologic diagnosis, surgical=20
procedure, caudal vena caval involvement (yes or no), postoperative=20
melena (yes or no), days in hospital after surgery, and whether=20
clinical signs of hyperadrenocorticism developed after surgery.=20
RESULTS: 130 ferrets were entered in the study (11 of 130 ferrets were=20
admitted and underwent surgery twice). The 1- and 2-year survival=20
rates were 98% and 88%, respectively. A 50% survival rate was never=20
reached. Combined partial adrenal gland resection with cryosurgery had=20
a significantly negative effect on survival time. No other risk=20
factors were identified. Survival time was not significantly affected=20
by either histopathologic diagnosis or specific affected adrenal gland=20
(right, left, or bilateral). CONCLUSIONS AND CLINICAL RELEVANCE:=20
Ferrets with adrenal gland masses that were treated surgically had a=20
good prognosis. Survival time of ferrets with hyperadrenocorticism=20
undergoing surgery was not affected by the histologic characteristic=20
of the tumor, the adrenal glands affected (right, left, or bilateral),=20
or complete versus partial adrenal gland resection. Debulking was a=20
sufficient surgical technique to allow a favorable long-term outcome=20
when complete excision was not possible.
PMID: 18447778 [PubMed - in process]
http://avmajournals.avma.org/doi/abs/10.2460/javma.232.9.1338
----
Vet Pathol. 2008 Mar;45(2):236-246.
Clinicopathologic Features of a Systemic Coronavirus-Associated=20
Disease Resembling Feline Infectious Peritonitis in the Domestic=20
Ferret (Mustela putorius).
Garner MM, Ramsell K, Morera N, Juan-Sall=C3=A9s C, Jim=C3=A9nez J, Ardiaca=
M,=20
Montesinos A, Teifke JP,L=C3=B6hr CV, Evermann JF, Baszler TV, Nordhausen =
RW, Wise AG, Maes RK, Kiupel M.
654=E2=80=85W. Main, Monroe, WA 98296 (USA). zoopath@aol.com.
From 2002 to 2007, 23 ferrets from Europe and the United States were=20
diagnosed with systemic pyogranulomatous inflammation resembling=20
feline infectious peritonitis (FIP). The average age at the time of=20
diagnosis was 11 months. The disease was progressive in all cases, and=20
average duration of clinical illness was 67 days. Common clinical=20
findings were anorexia, weight loss, diarrhea, and large, palpable=20
intra-abdominal masses; less frequent findings included hind limb=20
paresis, central nervous system signs, vomiting, and dyspnea. Frequent=20
hematologic findings were mild anemia, thrombocytopenia, and=20
hypergammaglobulinemia. Grossly, whitish nodules were found in=20
numerous tissues, most frequently the mesenteric adipose tissue and=20
lymph nodes, visceral peritoneum, liver, kidneys, spleen, and lungs.=20
One ferret had a serous abdominal effusion. Microscopically,=20
pyogranulomatous inflammation involved especially the visceral=20
peritoneum, mesenteric adipose tissue, liver, lungs, kidneys, lymph=20
nodes, spleen, pancreas, adrenal glands, and/or blood vessels.=20
Immunohistochemically, all cases were positive for coronavirus antigen=20
using monoclonal antibody FIPV3-70. Electron microscopic examination=20
of inflammatory lesions identified particles with coronavirus=20
morphology in the cytoplasm of macrophages. Partial sequencing of the=20
coronavirus spike gene obtained from frozen tissue indicates that the=20
virus is related to ferret enteric coronavirus.
http://www.vetpathology.org/cgi/content/full/45/2/236
----
Virology. 2008 May 2 [Epub ahead of print]
Virus growth and antibody responses following respiratory tract=20
infection of ferrets and mice with WT and P/V mutants of the=20
paramyxovirus Simian Virus 5.
Capraro GA, Johnson JB, Kock ND, Parks GD.
Department of Microbiology and Immunology, Wake Forest University=20
School of Medicine, Medical Center Boulevard, Winston-Salem, NC=20
27157-1064, USA.
P/V gene substitutions convert the non-cytopathic paramyxovirus Simian=20
Virus 5 (SV5), which is a poor inducer of host cell responses in human=20
tissue culture cells, into a mutant (P/V-CPI-) that induces high=20
levels of apoptosis, interferon (IFN)-beta, and proinflammatory=20
cytokines. However, the effect of SV5-P/V gene mutations on virus=20
growth and adaptive immune responses in animals has not been=20
determined. Here, we used two distinct animal model systems to test=20
the hypothesis that SV5-P/V mutants which are more potent activators=20
of innate responses in tissue culture will also elicit higher=20
antiviral antibody responses. In mouse cells, in vitro studies=20
identified a panel of SV5-P/V mutants that ranged in their ability to=20
limit IFN responses. Intranasal infection of mice with these WT and P/
V mutant viruses elicited equivalent anti-SV5 IgG responses at all=20
doses tested, and viral titers recovered from the respiratory tract=20
were indistinguishable. In primary cultures of ferret lung=20
fibroblasts, WT rSV5 and P/V-CPI- viruses had phenotypes similar to=20
those established in human cell lines, including differential=20
induction of IFN secretion, IFN signaling and apoptosis. Intranasal=20
infection of ferrets with a low dose of WT rSV5 elicited ~500 fold=20
higher anti-SV5 serum IgG responses compared to the P/V-CPI- mutant,=20
and this correlated with overall higher viral titers for the WT virus=20
in tracheal tissues. There was a dose-dependent increase in antibody=20
response to infection of ferrets with P/V-CPI-, but not with WT rSV5.=20
Together our data indicate that WT rSV5 and P/V mutants can elicit=20
distinct innate and adaptive immunity phenotypes in the ferret animal=20
model system, but not in the mouse system. We present a model for the=20
effect of P/V gene substitutions on SV5 growth and immune responses in=20
vivo.
http://www.sciencedirect.com/science?_ob=3DArticleURL&_udi=3DB6WXR-4SF9C4K-=
5&_user=3D10&_rdoc=3D1&_fmt=3D&_orig=3Dsearch&_sort=3Dd&view=3Dc&_acct=3DC0=
00050221&_version=3D1&_urlVersion=3D0&_userid=3D10&md5=3D86a1ff71a773144936=
c34554fd68c9d7
----
Virology. 2008 Apr 15 [Epub ahead of print] Links
Severe seasonal influenza in ferrets correlates with reduced=20
interferon and increased IL-6 induction.
Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V.
INRS-Institut Armand-Frappier, University of Quebec, Laval, QC, Canada.
Even though ferrets are one of the principal animal models for=20
influenza pathogenesis, the lack of suitable immunological reagents=20
has so far limited their use in host response studies. Using recently=20
established real-time PCR assays for a panel of ferret cytokines, we=20
analyzed the local ferret immune response to human influenza isolates=20
of the H1N1 and H3N2 subtypes that varied in their virulence. We=20
observed that the severity of clinical signs correlated with gross-=20
and histopathological changes in the lungs and was subtype-
independent. Strains causing a mild disease were associated with a=20
strong and rapid innate response and upregulation of IL-8, while=20
severe infections were characterized by a lesser induction of type I=20
and II interferons and strong IL-6 upregulation. These findings=20
suggest that more virulent strains may interfere more efficiently with=20
the host response at early disease stages.
PMID: 18420248 [PubMed - as supplied by publisher
http://www.sciencedirect.com/science?_ob=3DArticleURL&_udi=3DB6WXR-4S9FH17-=
1&_user=3D10&_rdoc=3D1&_fmt=3D&_orig=3Dsearch&_sort=3Dd&view=3Dc&_acct=3DC0=
00050221&_version=3D1&_urlVersion=3D0&_userid=3D10&md5=3D9072ec9831049be7f8=
23f5c3fe2ecf55
----
J Infect Dis. 2008 May 1;197(9):1315-1323.
Oseltamivir Prophylactic Regimens Prevent H5N1 Influenza Morbidity and=20
Mortality in a Ferret Model.
Boltz DA, Rehg JE, McClaren J, Webster RG, Govorkova EA.
1Department of Infectious Diseases (Division of Virology) and=20
2Department of Pathology, St. Jude Children=E2=80=99s Research Hospital, =
Memphis, Tennessee.
Background. @nbsp; Current oseltamivir prophylactic regimens may not=20
be as effective against highly pathogenic H5N1 influenza viruses as=20
they are against less pathogenic strains. An optimal regimen is=20
urgently needed. Methods. @nbsp; Ferrets were given the neuraminidase=20
inhibitor oseltamivir orally for 10 days (5 or 10 mg/kg once daily or=20
2.5 or 5 mg/kg twice daily). Prophylaxis was initiated 1 day before=20
infection, and oseltamivir was given 4 h before the ferrets were=20
inoculated with a lethal dose of A/Vietnam/1203/04 (H5N1) influenza=20
virus. Results. @nbsp; At a dose of 5 mg/kg once daily, oseltamivir=20
prevented death but not clinical signs of infection in ferrets; severe=20
pathology was observed in the lungs, brain, and liver. At 10 mg/kg=20
once daily, oseltamivir reduced clinical symptoms and systemic virus=20
replication, but pathology was observed in the internal organs. The=20
best results were obtained at a dose of 2.5 or 5 mg/kg given twice=20
daily. Both regimens resulted in 100% survival and the absence of=20
clinical symptoms, systemic virus spread, and organ pathology. Serum=20
antibody titers were comparable across regimens and were sufficient to=20
protect against rechallenge. Conclusions. @nbsp; An increased dose of=20
oseltamivir or twice-daily administration effectively protects ferrets=20
against morbidity and mortality caused by H5N1 infection and does not=20
interfere with the development of protective antibodies against=20
subsequent H5N1 infection.
PMID: 18422444
http://www.journals.uchicago.edu/doi/abs/10.1086/586711
----
Curr Protoc Immunol. 2001 May;Chapter 19:Unit 19.8.
Helicobacter animal models.
Nedrud JG, Blanchard TG.
Case Western Reserve University, Cleveland, Ohio, USA.
In this unit, protocols for growing Helicobacter organisms on plates=20
or in liquid cultures are presented, followed by protocols for=20
infecting mice with Helicobacter felis and H. pylori and for infecting=20
ferrets with H. mustelae. Also, a procedure is described for adapting=20
an H. pylori isolate to growth in mice. Support protocols describe=20
methods for quantifying numbers of Helicobacter organisms, and how to=20
create a growth curve for Helicobacter cultures. One important=20
technique in investigating Helicobacter infection is assaying the=20
disease processes that occur in the stomach, and a protocol is=20
provided for preparing tissue sections for this purpose. It is also=20
important to confirm that organisms recovered from tissue samples are,=20
in fact, Helicobacter species, and a support protocol describes=20
morphological and biochemical tests for this purpose. Helicobacter=20
bacteria produce large amounts of the enzyme urease, and a support=20
protocol describes how to perform a rapid urease test on animal-tissue=20
biopsies. Assays of Helicobacter-specific immune responses require=20
appropriate antigens, and preparation of both Helicobacter lysates and=20
outer-membrane proteins are detailed for use in these assays.
PMID: 18432759 [PubMed - in process
----
Theriogenology. 2008 Apr 24 [Epub ahead of print] Links
Use of a gonadotropin releasing hormone agonist implant as an=20
alternative for surgical castration in male ferrets (Mustela putorius=20
furo).
Schoemaker NJ, van Deijk R, Muijlaert B, Kik MJ, Kuijten AM, de Jong=20
FH, Trigg TE, Kruitwagen CL, Mol JA.
Department of Clinical Sciences of Companion Animals, Faculty of=20
Veterinary Medicine, Utrecht University, The Netherlands.
Surgical castration in ferrets has been implicated as an etiological=20
factor in the development of hyperadrenocorticism in this species due=20
to a castration-related increase in plasma gonadotropins. In search=20
for a suitable alternative, the effect of treatment with the depot=20
GnRH-agonist implant, deslorelin, on plasma testosterone=20
concentrations and concurrent testes size, spermatogenesis, and the=20
typical musky odor of intact male ferrets was investigated. Twenty-one=20
male ferrets, equally divided into three groups, were either=20
surgically castrated, received a slow release deslorelin implant or=20
received a placebo implant. Plasma FSH and testosterone=20
concentrations, testis size and spermatogenesis were all suppressed=20
after the use of the deslorelin implant. The musky odor in the ferrets=20
which had received a deslorelin implant was less compared to the=20
ferrets which were either surgically castrated or had received a=20
placebo implant. These results indicate that the deslorelin implant=20
effectively prevents reproduction and the musky odor of intact male=20
ferrets and is therefore considered a suitable alternative for=20
surgical castration in these animals.
http://linkinghub.elsevier.com/retrieve/pii/S0093-691X(08)00139-8
Sukie (not a vet)
Recommended ferret health links:
http://pets.groups.yahoo.com/group/ferrethealth/
http://ferrethealth.org/archive/
http://www.afip.org/ferrets/index.html
http://www.miamiferret.org/fhc/
http://www.ferretcongress.org/
http://www.trifl.org/index.shtml
http://homepage.mac.com/sukie/sukiesferretlinks.html
[Non-text portions of this message have been removed]
------------------------------------
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/ferrethealth/
<*> Your email settings:
Individual Email | Traditional
<*> To change settings online go to:
http://groups.yahoo.com/group/ferrethealth/join
(Yahoo! ID required)
<*> To change settings via email:
mailto:ferrethealth-digest@yahoogroups.com
mailto:ferrethealth-fullfeatured@yahoogroups.com
<*> To unsubscribe from this group, send an email to:
ferrethealth-unsubscribe@yahoogroups.com
<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/
Send comments to Pam at pjdutche@email.unc.edu. Please note that this address is only useful for questions about the FHL archive. Questions about ferret health, or those intended for the FHL, should be sent to the Ferret Health List.